Quick Answer
RenovoRx, Inc. reported Shares Outstanding of 36.61 million shares for fiscal year 2025.
RenovoRx, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 36.61M | +52.3% |
| 2024 | 24.03M | +124.8% |
| 2023 | 10.69M | +17.5% |
| 2022 | 9.10M | +1.8% |
| 2021 | 8.93M | +300.1% |
| 2020 | 2.23M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 36.65M | +52.7% | +0.0% |
| June 30, 2025 | 36.65M | +52.9% | +0.3% |
| March 31, 2025 | 36.55M | +116.7% | +52.1% |
| December 31, 2024 | 24.03M | +124.8% | +0.1% |
| September 30, 2024 | 24.00M | +124.5% | +0.1% |
| June 30, 2024 | 23.97M | +124.2% | +42.1% |
| March 31, 2024 | 16.87M | +84.7% | +57.7% |
| December 31, 2023 | 10.69M | +17.5% | +0.0% |
- RenovoRx, Inc. showed an increase of +52.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, RenovoRx, Inc.’s shares outstanding has grown by 1539.6% (from 2.23 million shares to 36.61 million shares).
- The most recent figure is from RenovoRx, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: